ONDCP Announces Two New Grants to Address Emerging Drug Threats and Improve Health in Tribal Communities

New Funding Will Help Build Capacity to Detect Emerging Drug Threats and Improve Health in Native American and Tribal Communities

WASHINGTON, DC – The White House Office of National Drug Control Policy (ONDCP) announced $600,000 in grant funding to support Tribal communities across America. 

A competitive grant for $300,000 was awarded to Marimn Health, the health authority of the Coeur d’Alene Tribe, to strengthen the community’s capacity to detect and address emerging drug threats. This project will integrate multiple drug data sources into a single monitoring system for the Coeur d’Alene Reservation and the surrounding five-county service area, and establish a standardized early warning protocol.  

An additional $300,000 was awarded to the Laureate Institute for Brain Research in Tulsa, Oklahoma, through the National Institute on Drug Abuse (NIDA) within the U.S. Department of Health and Human Services (HHS), to provide data science training to researchers to better serve Tribal members and improve Tribal health. This work is being done through the National Institutes of Health’s Adolescent Brain Cognitive DevelopmentSM (ABCD) study. The landmark ABCD study® is the largest long-term study of brain development and child and adolescent health ever conducted in the United States. This new funding represents a significant investment by ONDCP in the health of Native American and Tribal communities.

“Tribal communities are strong and resilient, but the drug crisis has hit these communities harder than anyone else,” said ONDCP Director Sara Carter. “The Trump Administration is committed to helping Tribal communities recover. With this new funding, we’re laying the groundwork that will help us stay ahead of emerging drug threats on Tribal lands and improve Tribal communities’ responses to these threats and to substance use. This is a priority for me, it’s a priority for the President, and we will continue fighting to make our Nation, including our Tribal communities, safer and healthier.”

This new funding comes at a time when the latest provisional data from the Centers for Disease Control and Prevention (CDC) show that in 2025, the age-adjusted drug overdose death rate of non-Hispanic American Indian and Alaska Native population was 157 percent higher than that of the national average (51.3 deaths per 100,000 vs. 20.0 deaths per 100,000), placing a significant burden on Tribal communities, health systems, and families.

Investing in Tribal communities is critical to decreasing the number of drug overdose deaths and promoting a drug-free America—key goals of the Trump Administration’s 2026 National Drug Control Strategy. Other top priorities include strengthening data systems, detecting and addressing emerging and evolving drug threats, and rapidly disseminating public warnings. This new funding will also support these goals.

To learn more about the 2026 National Drug Control Strategy, click here.

For more information about Marimn Health, click here.

For more information about the Laureate Institute for Brain Research, click here.

For more information about NIH’s ABCD Study, click here.

The White House Office of National Drug Control Policy leads and coordinates U.S. drug policy, develops and implements the President’s National Drug Control Strategy, and supports communities through the Drug Free Communities Support (DFC) and High Intensity Drug Trafficking Area (HIDTA) programs.

Related

Click to listen 0:00 2:57